Recombinant Human SLC51B Protein，His

SLC51B, also known as the small intestine-bile acid transporter (SIBAT), is part of the solute carrier family involved in the transport of bile acids across cell membranes. This protein is primarily expressed in the epithelial cells of the intestine and plays a crucial role in the enterohepatic circulation of bile acids, which are essential for lipid digestion and absorption. Recent studies have highlighted its significance in various physiological processes, including lipid metabolism, gut health, and the regulation of cholesterol levels. Dysregulation of SLC51B has been linked to several metabolic disorders, such as obesity, non-alcoholic fatty liver disease (NAFLD), and inflammatory bowel diseases. Research into SLC51B focuses on understanding its structural and functional properties, the mechanisms underlying its transport activity, and its potential as a therapeutic target for metabolic diseases. Innovative techniques, including molecular biology and biochemical assays, are employed to elucidate the pathways and regulatory networks involving SLC51B. Furthermore, studies on the effects of certain dietary components on SLC51B function may provide insights into nutritional strategies for managing metabolic health. As a result, SLC51B not only represents a critical player in bile acid homeostasis but also holds promise for the development of novel interventions aimed at improving metabolic health and preventing related diseases.